trending Market Intelligence /marketintelligence/en/news-insights/trending/8yyHRIUGFU1nvedVDDgaQA2 content esgSubNav
In This List

Galmed Pharmaceuticals launches $35M offering of ordinary shares

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Galmed Pharmaceuticals launches $35M offering of ordinary shares

Galmed Pharmaceuticals Ltd. plans to sell up to $35.0 million of its ordinary shares in an at-the-market equity offering from time to time.

Stifel Nicolaus & Co. Inc. is acting as the sales agent for the offering.